Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 126

1.

Hemangiogenesis and lymphangiogenesis in corneal pathology.

Tshionyi M, Shay E, Lunde E, Lin A, Han KY, Jain S, Chang JH, Azar DT.

Cornea. 2012 Jan;31(1):74-80. doi: 10.1097/ICO.0b013e31821dd986.

2.

Clinical and experimental research of corneal lymphangiogenesis after keratoplasty.

Ling S, Lin H, Xiang D, Feng G, Zhang X.

Ophthalmologica. 2008;222(5):308-16. doi: 10.1159/000144030. Epub 2008 Jul 10.

PMID:
18617753
3.

Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation.

Cursiefen C, Maruyama K, Jackson DG, Streilein JW, Kruse FE.

Cornea. 2006 May;25(4):443-7.

PMID:
16670483
4.

Lymphatic vessels in vascularized human corneas: immunohistochemical investigation using LYVE-1 and podoplanin.

Cursiefen C, Schlötzer-Schrehardt U, Küchle M, Sorokin L, Breiteneder-Geleff S, Alitalo K, Jackson D.

Invest Ophthalmol Vis Sci. 2002 Jul;43(7):2127-35.

PMID:
12091407
5.

Cellular-level characterization of lymph vessels in live, unlabeled corneas by in vivo confocal microscopy.

Peebo BB, Fagerholm P, Traneus-Röckert C, Lagali N.

Invest Ophthalmol Vis Sci. 2010 Feb;51(2):830-5. doi: 10.1167/iovs.09-4407. Epub 2009 Sep 24.

PMID:
19797212
6.

Lymphangiogenesis occurring in transplanted corneas.

Ling S, Qing X, Hu Y.

J Huazhong Univ Sci Technolog Med Sci. 2006;26(2):241-4.

PMID:
16850758
7.

Regulation of blood vessel versus lymphatic vessel growth in the cornea.

Chung ES, Saban DR, Chauhan SK, Dana R.

Invest Ophthalmol Vis Sci. 2009 Apr;50(4):1613-8. doi: 10.1167/iovs.08-2212. Epub 2008 Nov 21.

8.

Blockade of VEGFR3-signalling specifically inhibits lymphangiogenesis in inflammatory corneal neovascularisation.

Bock F, Onderka J, Dietrich T, Bachmann B, Pytowski B, Cursiefen C.

Graefes Arch Clin Exp Ophthalmol. 2008 Jan;246(1):115-9. Epub 2007 Oct 2.

PMID:
17909835
9.

b-FGF induces corneal blood and lymphatic vessel growth in a spatially distinct pattern.

Hajrasouliha AR, Sadrai Z, Chauhan SK, Dana R.

Cornea. 2012 Jul;31(7):804-9. doi: 10.1097/ICO.0b013e31823f8b5a.

10.

Novel expression and characterization of lymphatic vessel endothelial hyaluronate receptor 1 (LYVE-1) by conjunctival cells.

Chen L, Cursiefen C, Barabino S, Zhang Q, Dana MR.

Invest Ophthalmol Vis Sci. 2005 Dec;46(12):4536-40.

11.

Topical Ranibizumab inhibits inflammatory corneal hem- and lymphangiogenesis.

Bucher F, Parthasarathy A, Bergua A, Onderka J, Regenfuss B, Cursiefen C, Bock F.

Acta Ophthalmol. 2014 Mar;92(2):143-8. doi: 10.1111/j.1755-3768.2012.02525.x. Epub 2012 Sep 20.

12.

Regression of mature lymphatic vessels in the cornea by photodynamic therapy.

Bucher F, Bi Y, Gehlsen U, Hos D, Cursiefen C, Bock F.

Br J Ophthalmol. 2014 Mar;98(3):391-5. doi: 10.1136/bjophthalmol-2013-303887. Epub 2014 Jan 10.

PMID:
24414403
13.

Inhibition of Lymphangiogenesis and Hemangiogenesis in Corneal Inflammation by Subconjunctival Prox1 siRNA Injection in Rats.

Rho CR, Choi JS, Seo M, Lee SK, Joo CK.

Invest Ophthalmol Vis Sci. 2015 Sep;56(10):5871-9. doi: 10.1167/iovs.14-14433.

PMID:
26348636
14.

Dry eye predisposes to corneal neovascularization and lymphangiogenesis after corneal injury in a murine model.

Cho YK, Archer B, Ambati BK.

Cornea. 2014 Jun;33(6):621-7. doi: 10.1097/ICO.0000000000000107.

PMID:
24727637
15.

Serum eyedrops antagonize the anti(lymph)angiogenic effects of bevacizumab in vitro and in vivo.

Hos D, Koch KR, Bucher F, Bock F, Cursiefen C, Heindl LM.

Invest Ophthalmol Vis Sci. 2013 Sep 11;54(9):6133-42. doi: 10.1167/iovs.13-12460.

PMID:
23970469
16.

Differential distribution of blood and lymphatic vessels in the murine cornea.

Ecoiffier T, Yuen D, Chen L.

Invest Ophthalmol Vis Sci. 2010 May;51(5):2436-40. doi: 10.1167/iovs.09-4505. Epub 2009 Dec 17.

17.

Alkali burn versus suture-induced corneal neovascularization in C57BL/6 mice: an overview of two common animal models of corneal neovascularization.

Giacomini C, Ferrari G, Bignami F, Rama P.

Exp Eye Res. 2014 Apr;121:1-4. doi: 10.1016/j.exer.2014.02.005. Epub 2014 Feb 18.

PMID:
24560796
18.

Discontinuous LYVE-1 expression in corneal limbal lymphatics: dual function as microvalves and immunological hot spots.

Nakao S, Zandi S, Faez S, Kohno R, Hafezi-Moghadam A.

FASEB J. 2012 Feb;26(2):808-17. doi: 10.1096/fj.11-183897. Epub 2011 Nov 16.

19.

Limited versus total epithelial debridement ocular surface injury: Live fluorescence imaging of hemangiogenesis and lymphangiogenesis in Prox1-GFP/Flk1::Myr-mCherry mice.

Chang JH, Putra I, Huang YH, Chang M, Han K, Zhong W, Gao X, Wang S, Dugas-Ford J, Nguyen T, Hong YK, Azar DT.

Biochim Biophys Acta. 2016 Oct;1860(10):2148-56. doi: 10.1016/j.bbagen.2016.05.027. Epub 2016 May 24.

PMID:
27233452
20.

Short- and long-term corneal vascular effects of tafluprost eye drops.

Hos D, Koch KR, Bock F, Grajewski RS, Dietlein TS, Cursiefen C, Heindl LM.

Graefes Arch Clin Exp Ophthalmol. 2013 Aug;251(8):1919-27. doi: 10.1007/s00417-013-2345-0. Epub 2013 Apr 28.

PMID:
23624591

Supplemental Content

Support Center